Continuous Infusion Topotecan With Erlotinib for Topotecan Pretreated Ovarian Cancer: Tumor Features and Phase II/Pharmacokinetic Evaluation.
Phase of Trial: Phase II
Latest Information Update: 02 Dec 2013
At a glance
- Drugs Erlotinib (Primary) ; Topotecan (Primary)
- Indications Ovarian cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 01 Dec 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 05 Oct 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.